---
figid: PMC9641715__mmr-26-06-12877-g01
pmcid: PMC9641715
image_filename: mmr-26-06-12877-g01.jpg
figure_link: /pmc/articles/PMC9641715/figure/f2-mmr-26-06-12877/
number: Figure 2
figure_title: ''
caption: 'Inhibitory effect of ACT on DSS-induced inflammation of the colon tissues.
  (A) Inhibitory effect of ACT on DSS-induced levels of inflammatory cytokines, including
  TNF-α, IL-1β and IL-6, assessed using ELISA. (B) Inhibitory effect of ACT on DSS-induced
  alterations in the levels of MDA, CAT, GSH and SOD. n=6. ***P<0.001 vs. control;
  #P<0.05, ##P<0.01 and ###P<0.001 vs. DSS. ACT, acteoside; DSS, dextran sulphate
  sodium; MDA, malondialdehyde; CAT, catalase; GSH, glutathione; SOD, superoxide dismutase.'
article_title: Acteoside alleviates dextran sulphate sodium-induced ulcerative colitis
  via regulation of the HO-1/HMGB1 signaling pathway.
citation: Wenjuan Guo, et al. Mol Med Rep. 2022 Dec;26(6):360.
year: '2022'

doi: 10.3892/mmr.2022.12877
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos

keywords:
- acteoside
- ulcerative colitis
- high mobility group box 1 protein
- heme oxygenase-1

---
